CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +89,700 | 427,801 | ||
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −32,005 | $0.39 | $12K | 395,796 |
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +111,000 | 506,796 | ||
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −39,605 | $0.39 | $15K | 467,191 |
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −89,700 | 269,100 | ||
| 2024-12-16 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −111,000 | 222,000 | ||
| 2024-12-10 | Charlton Ralph William III CHIEF MEDICAL OFFICER | Option exercise | +106,400 | 161,773 | ||
| 2024-12-10 | Charlton Ralph William III CHIEF MEDICAL OFFICER | Shares withheld for taxes | −37,964 | $0.54 | $20K | 123,809 |
| 2024-12-10 | Charlton Ralph William III CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −106,400 | 106,400 | ||
| 2024-12-10 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | +154,000 | 356,776 | ||
| 2024-12-10 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for taxes | −54,948 | $0.54 | $30K | 301,828 |
| 2024-12-10 | Gharib Samir M. PRESIDENT AND CFO | Option exercise · Restricted Stock Units | −154,000 | 154,000 | ||
| 2024-12-10 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +358,800 | 466,121 | ||
| 2024-12-10 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −128,020 | $0.54 | $69K | 338,101 |
| 2024-12-10 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −358,800 | 358,800 | ||
| 2024-05-22 | Ways Kirk Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-22 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-22 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-22 | Muralidhar Bali Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-22 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 7 of 12 · 231 trades